Vimarsana
Biggest News Aggregation in the World

Page 20 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

bluebird bio, Inc. (NASDAQ:BLUE) Q3 2023 Earnings Call Transcript - Vimarsana News

bluebird bio, Inc. (NASDAQ:BLUE) Q3 2023 Earnings Call Transcript

Bluebird bio, Inc. (NASDAQ:BLUE) Q3 2023 Earnings Call Transcript November 7, 2023 bluebird bio, Inc. beats earnings expectations. Reported EPS is $-0.66, expectations were $-0.69. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the bluebird bio Third Quarter 2023 Results Conference Call. At this time, all participants are in […]

Source: yahoo.com
FDA Approves Diabetes Drug Tirzepatide for Chronic Weight Management - Vimarsana News

FDA Approves Diabetes Drug Tirzepatide for Chronic Weight Management

Tirzepatide is already approved to treat type 2 diabetes, and is now approved for chronic weight management in adults with obesity or overweight with at least 1 weight-related condition.

Source: ajmc.com
FDA Approves Erosive GERD Therapy Vonoprazan - Vimarsana News

FDA Approves Erosive GERD Therapy Vonoprazan

Phathom Pharmaceuticals' vonoprazan (Voquenza) sets a new standard in erosive gastroesophageal reflux disease (GERD) therapy.

Source: ajmc.com
FDA Approval of Momelotinib May Establish New SOC for Myelofibrosis With Anemia - Vimarsana News

FDA Approval of Momelotinib May Establish New SOC for Myelofibrosis With Anemia

Andrew T. Kuykendall, MD, discusses the importance of the approval of momelotinib in the treatment of patients with anemic symptomatic myelofibrosis, key efficacy and safety data from the MOMENTUM trial that supported the decision, and unanswered questions regarding the agent’s potential role in other subsets within this population.

POLARIS[AR] RECEIVES CLEARANCE FROM THE U.S. FOOD AND DRUG ADMINISTRATION FOR STELLAR KNEE - Vimarsana News

POLARIS[AR] RECEIVES CLEARANCE FROM THE U.S. FOOD AND DRUG ADMINISTRATION FOR STELLAR KNEE

/PRNewswire/ -- POLARISAR is pleased to announce today that their STELLAR Knee has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)....